The Potential of N-Acetyl-L-Cysteine (NAC) in the Treatment of Psychiatric Disorders

RCJ Bradlow, M Berk, PW Kalivas, SE Back… - CNS drugs, 2022 - Springer
Abstract N-acetyl-L-cysteine (NAC) is a compound of increasing interest in the treatment of
psychiatric disorders. Primarily through its antioxidant, anti-inflammatory, and glutamate …

N-acetylcysteine in substance use disorder: a lesson from preclinical and clinical research

I Smaga, M Frankowska, M Filip - Pharmacological Reports, 2021 - Springer
Substance use disorder (SUD) is a chronic brain condition, with compulsive and
uncontrollable drug-seeking that leads to long-lasting and harmful consequences. The …

Natural and synthetic estrogens specifically alter nicotine demand and cue-induced nicotine seeking in female rats

EE Maher, PF Overby, AH Bull, JS Beckmann… - …, 2021 - Elsevier
Women have more difficulty maintaining smoking cessation than men, and experience
greater withdrawal symptomatology as well as higher prevalence of relapse. Further …

Psychosocial and pharmacological treatments for cannabis use disorder and mental health comorbidities: a narrative review

R Lees, LA Hines, DC D'Souza, G Stothart… - Psychological …, 2021 - cambridge.org
Cannabis is the most widely used illicit drug worldwide, and it is estimated that up to 30% of
people who use cannabis will develop a cannabis use disorder (CUD). Demand for …

Treatments for Cannabis Use Disorder across the Lifespan: A Systematic Review

M Ghafouri, S Correa da Costa, A Zare Dehnavi… - Brain Sciences, 2024 - mdpi.com
Cannabis use disorder (CUD) is a growing public health concern, with rising prevalence and
significant impact on individuals across age groups. This systematic review examines 24 …

N-acetyl cysteine in the treatment of cannabis use disorder: A systematic review of clinical trials

R Sharma, SK Tikka, AR Bhute, BK Bastia - Addictive Behaviors, 2022 - Elsevier
Abstract Background and Aim Cannabis is the most consumed illicit drug globally, with a
high risk of developing cannabis use disorder (CUD). No approved pharmacological …

[HTML][HTML] N-acetylcysteine improves impulse control and attenuates relapse-like alcohol intake in long-term drinking rats

I Fredriksson, N Jayaram-Lindström, PW Kalivas… - Behavioural Brain …, 2023 - Elsevier
Increasing evidence suggests that individuals with alcohol use disorder (AUD) present with
a disrupted glutamatergic system that underlies core components of addictive disorders …

Advancements in addressing drug dependence: A review of promising therapeutic strategies and interventions

CR Guida, JM Maia, LFR Ferreira, A Rahdar… - Progress in Neuro …, 2024 - Elsevier
Substance dependence represents a pervasive global concern within the realm of public
health. Presently, it is delineated as a persistent and recurrent neurological disorder …

Influence of n-acetylcysteine maintenance on the pharmacodynamic effects of oral ethanol

WW Stoops, JC Strickland, LR Hays… - Pharmacology …, 2020 - Elsevier
Rationale Glutamate systems play an important role in the abuse related effects of alcohol. n-
Acetylcysteine, a drug that promotes glutamate homeostasis, attenuates a range of alcohol …

Clinical approaches to Cannabis: A narrative review

DE Slawek, SA Curtis, JH Arnsten… - Medical …, 2022 - medical.theclinics.com
Background In the late nineteenth and early twentieth centuries, cannabis in the United
States was mostly restricted to medical use, including for the management of pain …